About Careers MedBlog Contact us

50% Prostate Cancer Cases Wrongly Classified Initially: Study

by Anubha Sinha on April 11, 2014 at 10:42 PM
Font : A-A+

50% Prostate Cancer Cases Wrongly Classified Initially: Study

Researchers have revealed that in over half of prostate cancer cases, doctors are not able to inform about the seriousness of the case after the initial diagnosis.

Urological surgeon Greg Shaw from the Cancer Research UK Cambridge Institute, said, "Our results show that the severity of around half of men's prostate cancers may be underestimated when relying on tests before surgery."


The scientists said that in 50 per cent cases, doctors make wrong classification of the prostate cancer initially and later they turned out to be dangerous tumours. They said doctors did not give much heed to these patients until tests suggest their condition had worsened.

For the study, 847 men with prostate cancer were tracked. Out of the 415 who were initially told their cancer was slow-growing, 209 were found to have a more aggressive form of the disease.

Scientists are also calling for better diagnosis which can help prostate cancer victims.

Prostate cancer is the most common male cancer in the UK. Each year, 41,700 new cases are detected with 10,800 reported deaths.

Shaw said, "This highlights the urgent need for better tests to define how aggressive a prostate cancer is from the outset, building on diagnostic tests like MRI (magnetic resonance imaging) scans, and new biopsy techniques which help to more accurately define the extent of the prostate cancer."

Slow-growing prostate cancers are called pussycats, while the more aggressive and dangerous are called tiger. The 'tiger' may spread quickly if it is not surgically removed or destroyed.

The findings were published in British Journal of Cancer.

Source: Medindia


Recommended Reading

Latest Cancer News

Exploring the Role of Neutrophils in Immunotherapy
Neutrophils, the blood cell types are mobilized to fight cancer if they are appropriately engaged.
How Can Mouse Avatars Help Treat Multiple Myeloma?
The mouse avatars created help study and develop personalized treatments against blood cancer - myeloma.
Why Is Time of Day Important in Cancer Diagnosis and Treatment?
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
How Do Neutrophils Impact Pancreatic Cancer Treatment Resistance?
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

50% Prostate Cancer Cases Wrongly Classified Initially: Study Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests